logo

CPRX

CatalystยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CPRX Profile

Catalyst Pharmaceuticals, Inc.

A commercial-stage biopharmaceutical company that develops prescription drugs for neuromuscular and neurological diseases and disorders

Biological Technology
--
11/08/2006
NASDAQ Stock Exchange
181
12-31
Common stock
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134
--
Catalyst Pharmaceuticals, Inc., was incorporated in Delaware in July 2006. The Company is a commercial-stage, patient-centric biopharmaceutical company focused on the licensing, development and commercialization of new high-quality medicines for patients with rare and difficult-to-treat diseases. The company uses a concerted and diligent effort to find therapies that can improve the lives of those with rare or difficult-to-treat diseases.